Failure pattern implications following external beam irradiation of prostate cancer: long-term follow-up and indications of cure. Alexandra L. Hanlon, Ph.D.,a,b Gerald E. Hanks, M.D.,b Departments of aRadiation Oncology and bBiostatistics, Fox Chase Cancer Center, Philadelphia, PA, USA.Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. Anthony V. D'Amico, Richard Whittington, S. Bruce Malkowicz, Delray Schultz, Julia Fondurulia, Ming-Hui Chen, John E. Tomaszewski, Andrew A. Renshaw, Alan Wein, and Jerome P. Richie, Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA 02215, USA.Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group.Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. Robert E. Tarone, Kenneth C. Chu, and Otis W. Brawley, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
2001 ◽
Vol 6
(3)
◽
pp. 123-124
Keyword(s):
2004 ◽
Vol 60
(1)
◽
pp. S379
Keyword(s):
2004 ◽
Vol 60
◽
pp. S379-S379
Keyword(s):
2012 ◽
Vol 84
(3)
◽
pp. S92
2017 ◽
Vol 26
(6)
◽
pp. 1635-1645
◽
Keyword(s):
Keyword(s):